<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Cancer / Virotherapy / Biotechnology / Experimental cancer treatments / Antineoplastic drugs / Cancer treatments / Melanoma / Oncolytic virus / Oncolytic herpes virus / Ipilimumab
Date: 2016-03-02 10:23:54
Medicine
Clinical medicine
Cancer
Virotherapy
Biotechnology
Experimental cancer treatments
Antineoplastic drugs
Cancer treatments
Melanoma
Oncolytic virus
Oncolytic herpes virus
Ipilimumab

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

Add to Reading List

Source URL: moffitt.org

Download Document from Source Website

File Size: 423,20 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile.  Photo courtesy of Dina Potter. Sunny Tree. 48

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

DocID: 1rePY - View Document

FOR	
  IMMEDIATE	
  RELEASE	
   	
   	
    

FOR  IMMEDIATE  RELEASE        

DocID: 1pOi3 - View Document

WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

DocID: 1nhVB - View Document

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

DocID: 1gtbO - View Document